Match tier Confirmed
Presence Current · Arkansas
Last published 2021
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Matthew C. White

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Associate Professor

NCTR Arkansas Colleges of Health Education primary

Also affiliated: Texas Tech University (2009); United States Food and Drug Administration (2016–2018); The University of Texas MD Anderson Cancer Center (2011–2018); ToxStrategies LLC (United States) (2015); The University of Texas Health Science Center at Houston (2013)

8 h-index 20 pubs 321 cited

Biomedical Subjects

  • Humans
  • Animals
  • Dose-Response Relationship, Drug
  • Female
  • Male
  • Rats
  • Toxicity Tests
  • Species Specificity
  • Reactive Oxygen Species
  • Protein Kinase Inhibitors
  • Chemical and Drug Induced Liver Injury
  • Bortezomib
  • Cell Death
  • Cell Line, Tumor
  • Adult

Links

ORCID

Metrics

  • h-index: 8
  • Publications: 20
  • Citations: 321

Positions

  • Associate Professor publications 2018–2021
    Arkansas Colleges of Health Education Molecular & Cellular Biology ORCID

Selected Publications

  • At the intersection of sulfur redox chemistry, cellular signal transduction and proteostasis: A useful perspective from which to understand and treat neurodegeneration (2021)
    Free Radical Biology and Medicine 15 citations DOI OpenAlex
  • Stable knockout of lanthionine synthase C-like protein-1 (LanCL1) from HeLa cells indicates a role for LanCL1 in redox regulation of deubiquitinating enzymes (2020)
    Free Radical Biology and Medicine 8 citations DOI OpenAlex
  • Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research (2019)
    Toxicology in Vitro 4 citations DOI OpenAlex
  • Abstract 17363: Inter-Individual Heterogeneity Among Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Response to Kinase Inhibitors (2018)
    Circulation DOI OpenAlex
  • Abstract 17064: Enrichment of Cardiotoxic Gene Expression Profile in Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes in Response to Tyrosine Kinase Inhibitor Nilotinib (2018)
    Circulation DOI OpenAlex
  • Cytotoxicity of 34 FDA approved small-molecule kinase inhibitors in primary rat and human hepatocytes (2018)
    Toxicology Letters 37 citations DOI OpenAlex
  • Induced Pluripotent Stem Cell-Derived Cardiomyocytes: An In Vitro Model to Predict Tyrosine Kinase Inhibitor (TKI)-Induced Structural Cardiotoxicity (2017)
    Journal of Pharmacological and Toxicological Methods DOI OpenAlex
  • Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria (2016)
    Archives of Toxicology 98 citations DOI OpenAlex
  • MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity? (2016)
    Food and Chemical Toxicology 17 citations DOI OpenAlex

View all publications on OpenAlex →